Study of Urinary Protein Biomarkers in Hereditary Angioedema
Journal of Investigational Allergology and Clinical Immunology · 14.10.2025 · 35 (5) · 353-363
DOI: 10.18176/jiaci.1032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigational Allergology and Clinical Immunology, online erschienen am 15.10.2025. Verfasst von J Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, National Infrastructure for Translational Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical…. Hauptthemen laut MEDLINE: Biomarkers, Angioedemas, Hereditary. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Hereditary angioedema (HAE) is a rare and potentially life-threatening disease, and diagnosis is often missed or delayed. We aimed to identify noninvasive urinary protein biomarkers and to evaluate their potential roles in diagnosis and evaluation of disease severity.
Methods
Using data-independent acquisition (DIA)–based urinary proteomics, we identified proteins that were differentially expressed between patients with HAE and healthy control (HC) groups. Then, the parallel reaction monitoring (PRM)–targeted proteomics method was used to validate promising biomarker candidates in other HAE patients and HCs. Furthermore, enzyme-linked immunosorbent assay (ELISA) was conducted to verify levels of several key proteins in HAE, histamine-mediated angioedema, and HCs.
Results
Differential expression between HAE patients and HCs was observed in 269 of the 2562 urinary proteins identified. In the biofunction analysis, these differentially expressed proteins were significantly enriched in leukocyte migration, adhesion of immune cells, endothelial cell development, permeability of the vascular system, and death of immune cells. Moreover, a biomarker panel (C1 esterase inhibitor, pro-epidermal growth factor, and kininogen-1) was validated in 2 independent clinical cohorts with area under the curve values of 0.910 and 0.949 for a diagnosis of HAE. Additionally, the urinary clusterin level was found to be significantly correlated with HAE severity scores (R=–0.758, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine, National Infrastructure for Translational Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
- State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine P…
- Department of Allergy and Clinical Immunology, National Clinical Research Center for Immunologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Bei…
- Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zitieren
APA
Wu, J., Tang, X., Zhou, N., Wang, X., Liu, P., Zhang, Z., Zhang, S., & Zhi, Y. (2025). Study of Urinary Protein Biomarkers in Hereditary Angioedema. Journal of Investigational Allergology and Clinical Immunology, 35(5), 353-363. https://doi.org/10.18176/jiaci.1032
Vancouver
Wu J, Tang X, Zhou N, Wang X, Liu P, Zhang Z, et al. Study of Urinary Protein Biomarkers in Hereditary Angioedema. Journal of Investigational Allergology and Clinical Immunology. 2025;35(5):353-363. doi:10.18176/jiaci.1032
BibTeX
@article{Wu2025,
author = {Wu, J and Tang, X and Zhou, N and Wang, X and Liu, P and Zhang, Z and Zhang, S and Zhi, Y},
title = {Study of Urinary Protein Biomarkers in Hereditary Angioedema},
journal = {Journal of Investigational Allergology and Clinical Immunology},
year = {2025},
volume = {35},
number = {5},
pages = {353--363},
doi = {10.18176/jiaci.1032}
}
EUVIMED